US Patent 8343501 Bispecific EGFR/IGFIR binding molecules
Patent 8343501 was granted and assigned to Bristol-Myers Squibb on January, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8343501 Bispecific EGFR/IGFIR binding molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.